Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.

A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target.

The sphere-forming frequency of neuroblastoma cells is a measure of their proliferative capacity and could help guide treatment strategies for neuroblastoma.

Increased activity of the “fight or flight” nervous system contributes to obesity-associated hypertension and may be a good therapeutic target for the disease.

Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers.

Children with Prader-Willi Syndrome who received growth hormone treatment had cognitive advantages compared to untreated patients.

A peptide molecule relaxes airway smooth muscle and may be a potential therapeutic for asthma that has become resistant to standard therapies.